References

nnp

Neurology, Neuropsychiatry, Psychosomatics

Неврология, нейропсихиатрия, психосоматика

2074-27112310-1342

"IMA-Press", LLC

10.14412/2074-2711-2012-2506

nnp-237

Research Article

Articles

Статьи

Diabetic encephalopathy

Диабетическая энцефалопатия

Строков

И. А.

Strokov

I. A.

strigoral@mail.ru

Захаров

В. В.

Zakharov

V. V.

strigoral@mail.ru

Строков

К. И.

Strokov

K. I.

strigoral@mail.ru

Кафедра нервных болезней лечебного факультета ГБОУ ВПО Первого МГМУ им. И.М. Сеченова, МоскваРоссияDepartment of Nervous System Diseases, I.I. Sechenov First Moscow State Medical University, MoscowRussian Federation

Кафедра эндокринологии и диабетологии РМАПО, МоскваРоссияDepartment of Endocrinology and Diabetology, Russian Medical Academy of Postgraduate Education, MoscowRussian Federation

2012

10062012

42S

Сognitive and other neuropsychiatric disorders

3040

2014

Строков И.А., Захаров В.В., Строков К.И.

Strokov I.A., Zakharov V.V., Strokov K.I.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://nnp.ima-press.net/nnp/article/view/237

The epidemiology, clinical presentation, morphology, and pathogenesis of central nervous system lesion in types 1 and 2 diabetes mellitus (DM) are considered, by using the results of experimental and clinical studies. The definition of diabetic encephalopathy is given. Whether there is a relationship between diabetic encephalopathy and diabetic polyneuropathy is considered. It is concluded that it is expedient to identify diabetic encephalopathy as a complication of DM. The capacities of pathogenetic treatment for diabetic encephalopathy are shown.

На основании результатов экспериментальных и клинических исследований рассмотрены вопросы эпидемиологии, клиники, морфологии и патогенеза поражения ЦНС при сахарном диабете (СД) 1-го и 2-го типов. Сформулировано определение диабетической энцефалопатии. Рассмотрен вопрос о взаимоотношении диабетической энцефалопатии с диабетической полиневропатией. Сделано заключение о целесообразности выделения диабетической энцефалопатии в качестве осложнения СД. Представлены возможности патогенетического лечения диабетической энцефалопатии.

диабетическая энцефалопатияпериферическая полиневропатиясахарный диабет

diabetic encephalopathyperipheral polyneuropathydiabetes mellitus

References1

<div>Чугунов П.А., Семенова И.В. Сахарный диабет и когнитивные нарушения. Сахарн диаб 2008;1:61–8.McGuire L.C., Ford E.S., Ajani U.A. The impact of cognitive functioning on mortality and the development of functional disability in older adults with diabetes: the second longitudinal study on aging. BMC Geriatrics 2006;6(8):58–62.Biessels G.J. Cerebral complications of diabetes: clinical findings and pathogenetic mechanisms. Neth J Med 1999;54:35–45.Ryan C.M., Geckle M.O. Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care 2000;23:1486–93.Manschot S.M., Biessels G.J., de Valk H. et al. Metabolic and vascular determinations of impaired cognitive performance and abnormalities of brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007;50(11):2388–97.De Bresser J., Reijmer Y.D., van der Berg E. et al. Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes. Dement Geriatr Dis 2010;30(5):381–6.Сосина В.Б., Захаров В.В., Яхно Н.Н. Недементные когнитивные нарушения у больных сахарным диабетом 2 типа. Неврол журнал 2010;4.Захаров В.В., Сосина В.Б. Когнитивные нарушения у больных сахарным диабетом. Неврол журнал 2009;4:54–8.Bruce D.G., Casey G.P., Drange V. et al. Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study. Diab Res Clin Pract 2003;61:59–67.Gregg W.E, Brown A.A. Cognitive and Physical Disabilities and Aging-Related Complications of Diabetes. Clin Diab 2003;21:113–18.Biessels G.J., van der Heide L.P., Kamal A. et al. Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002;441:1–14.Ott A., Stolk R.P., Hofman A. et al. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996;39:1392–7.Leibson C.L., Rocca W.A., Hanson V.A. et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 1997;145:301–8.Scott R.D., Kritz-Silverstein D., Barrett-Connor E. et al. The association of non-insulin-dependent diabetes mellitus and cognitive function in an older cohort. J Am Geriatr Soc 1998;46:1217–22.Lindeman R.D., Romero L.J., LaRue A. et al. A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey. Diab Care 2001;24:1567–72.Cosway R., Strachan M.W., Dougall A., et al. Cognitive function and information processing in type 2 diabetes. Diab Med 2001;18:803–10.Строков И.А., Моргоева Ф.Э., Строков К.И. и др. Терапевтическая коррекция диабетической полиневропатии и энцефалопатии Актовегином. РМЖ 2006;9:698–703.Augustina M.A. Brands A.M. et al. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. Eur J Pharmacol 2004;490:159–68.Grodstein F., Chen J., Wilson R.S. et al. Type 2 Diabetes and Cognitive Function in Community-Dwelling Elderly Women. Diab Care 2001;24:1060–5.Curb J.D., Rodriguez B.L., Abbott R.D. et al. Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance. Neurology 1999;52:971–5.Kanaya A.M., Barrett-Connor E., Gildengorin G. et al. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Int Med 2004;164:1327–33.Kalmijn S., Feskens E.J.M., Launer L.J. et al. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 1995;38:1096–102.Asimakopoulou K., Hampson S.E. Cognitive Functioning and Self-Management in Older People With Diabetes. Diab Spectr 2002;15:116–21.Hassing L.B., Hofer S.M., Nilsson S.E.et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age and Ageing 2004;33:355–61.Posner H.B., Tang M.-X., Luchsinger J. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002;58:1175–81.Елфимова Е.В., Коркина М.В. Сахарный диабет и депрессия. Журн неврол и психиатр 2003;12:66–70.Peyrot M., Rubin R.R. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diab Care 1997;20:585–90.Anderson R.J., Freedland K.E. The prevalence of comorbid depression in adults with diabetes: a meta-analysis.Diab Care 2001;24(6):1069–78.Котов С.В., Рудакова И.Г., Исакова Е.В. Энцефалопатия у больных сахарным диабетом II типа. Клиника и лечение. Неврол журн 2001;3:35–7.Яхно Н.Н. Когнитивные расстройства в неврологической клинике. Неврол журн 2006;11(Прил 1):4–12.Яхно Н.Н., Захаров В.В., Локшина А.Б. и др. Деменции. Рук-во для врачей. М.: Медпресс-информ, 2011;264 с.Захаров В.В., Яхно Н.Н. Когнитивные расстройства в пожилом и старческом возрасте. Метод. пособ. для врачей. М., 2005;71 с.Локшина А.Б., Захаров В.В. Легкие и умеренные когнитивные расстройства при дисциркуляторной энцефалопатии. Неврол журн 2006;11(Прил. 1):57–64.Ryan C.M., Williams T.M. Effects of insulin-dependent diabetes on learning and memory efficiency in adults. J Clin Exp Neuropsychol 1993;15:685–700.Strachan M.W.J., Deary I.J., Ewing R.M.E. et al. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diab Care 1997;20:438–45.Kold C.T., Seaquist E.R. Cognitive Dysfunction and Diabetes Mellitus. Endocrin Rev 2008;29(4):494–511.Gregg E.W., Engelgau M.E., Narayan K.M.V. Cognitive decline, physical disability, and other unappreciated outcomes of diabetes and aging. BMJ 2002;325:916–17.Arvanitakis Z., Wilson R.S., Schneider J.A. et al. Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology 2004;63(6):996–1001.Tamara B., Harris L., Lenore J. et al. Age, Gene/Environment Susceptibility–Reykjavik Study: Multidisciplinary Applied Phenomics. Am J Epidemiol 2007;165(9):1076–87.Luchsinger J.A., Tang M.X., Stern Y. et. al. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001;154:635–41.Miles W.R., Root H.F. Psychologic tests applied in diabetic patients. Arch Int Med 1922;30:767–77.Reske-Nielsen E., Lundbaek K., Rafeisen Q.J. Pathological changes in the cerebral and peripheral nervous system of young long-term diabetics. Diabetic encephalopathy. Diabetologia 1965;1:233–41.Brownly M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–20.Cardoso S., Santos M.S., Seiça R. et al. Cortical and hippocampal mitochondria bioenergetics and oxidative stutus during hyperglicemia and/or insulin-induced hypoglicemia. Biochim Biol Acta 2010;1802:942–51.Makar T.K., Rimpel-Lamhaouar K., Abraham D.G. et al. Antioxidant defence systems in the brains of type II diabetic mice. J Neurochem 1995;65:287–91.Ryle C., Leow C.K., Donaghy M. Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus. Muscle Nerve 1997;20:577–84.Toth C., Schmidt A.M., Tuor U.I. et al. Diabetes, leukoencephalopathy and rage. Neurobiol Dis 2006;23:445–61.Mankovsky B.N., Metzger B.E., Molitch M.E. et al. Cerebrovascular disorders in patients with diabetes mellitus. J Diab Compl 1997;10:228–42.Manschot S.M., Augustina M.A., Brands A. et al. Brain Magnetic Resonance Imaging Correlates of Impaired Cognition in Patients With Type 2 Diabetes. Diab Care 2006;55:1106–13.Biessels G.J., Kappelle A.C., Bravenboer B. et al. Cerebral function in diabetes mellitus. Diabetologia 1994;37:643–50.Kamal A., Biessels G.J., Urban I.J. et al. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neurosci 1999;90:737–45.Welsh B., Wecker L. Effects of streptozotocin-induced diabetes on acetylcholine metabolism in rat brain. Neurochem Res 1991;16:453–60.Seaquist E.R., Damberg G.S. et al. The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes 2001;50:2203–9.Bingham E.M., Hopkins D., Smith D. et. al. The role of insulin in human brain glucose metabolism: an 18-fluoro-deoxyglucose positron emission tomography study. Diabetes 2001;51:3384–90.Freychet P. Insulin receptors and insulin actions in the nervous system. Diab Metab Res Rev 2000;16(6):390–2.Gispen W.H., Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Eur J Pharmacol 2000;223:656–8.Niiya Y., Abumiya T., Shichinohe H. et al. Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species. Brain Res 2006;1108:179–87.Kold C.T., Seaquist E.R. Cognitive Dysfunction and Diabetes Mellitus. Endocrine Rev 2008;29(4):494–511.Araki Y., Nomura M., Tanaka H. et al. MRI of the brain in diabetes mellitus. Neuroradiol 1994;36:101–3.Nomiyama T., Tanaka Y., Hattori N. et al. Accumulation of somatic mutation in mitochondrial DNA extracted from peripheral blood cells in diabetic patients. Diabetologia 2002;45(11):1577–83.Peress N.S., Kane W.C., Aronson S.M. Central nervous system findings in a tenth decade autopsy population. Progr Brain Res 1973;40:473–83.Wessels A.M., Simsek S., Remijnse P.L. et al. Voxel-based morphometry demonstretes reduced gray matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 2006;49(10):2474–80.Ziegler D., Muhlen H., Dannehl K. et al. Tibial nerve somatosensory evoked potentials at various stages of peripheral neuropathy in type 1 diabetic patients. J Neurol Neurosurg Psychiatr 1993;56:58–64.Pozzessere G., Valle E., de Crignis S. et al. Abnormalities of cognitive functions in IDDM relealed by P300 event-related potential analysis. Diabetes 1991;40:952–8.Watson G.S., Craft S. The role of insulin resistance in the pathogenesis of Alzheimer’s disease: implications for treatment. CNS Drugs 2003;17:27–32.Arvanitakis Z., Wilson R.S., Bienias J.L. et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004;61:661–6.Cassels C., Vega C. Chronically high blood glucose linked with cognitive impairment risk. J Nutr Health Aging 2006;10:293–5.Hoyer S. Is sporadic Alzheimer’s disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Trans 1998;105:415–22.Hoyer S. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). J Neural Trans 2002;109(7):991–1002.Honig L.S., Mayeux R. Natural history of Alzheimer's disease. Aging (Milano) 2001;13(3):171–82.Takeuchi M., Yamagishi S. Involment of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease. J Alzheim Dis 2009;16(4):845–58.Beeler N., Riederer B.M., Waeber G. et al. Role of the JNK-interacting protein 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes. Brain Res Bull 2009;80:274–81.Liu Y.W., Liu L., Lu S.S. et al. Impaired amiloid beta-degrading enzymes in brain of streptozotocin-induced diabetic rats. J Endocrin Invest 2010; PubMed, PMID 20414044.Haan M., Mungas D.M., Gonzalez H.M. Prevalence dementia in older latinos: the influence of diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc 2003;51:169–77.Reichard P., Britz A., Cars I. et al. The Stockholm Diabetes Intervention Study (SDIS): 18 months' results. Acta Med Scand 1988;224(2):115–22.Nathan D.M., Cleary P.A., Backlund J.Y. et. al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643–53.The DCCT/EDIC study research groop. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007;356:1842–52.UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS. Br Med J 1998;317:703–13.UK Prospective Diabetes Study Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854–65.UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53.Manschot S.M., Biessels G.J., Cameron N.E. et al. Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cere,hfk blood flow in streptozotocin-diabetic rat. Brain Res 2003;966(2):274–82.Sima A.A., Li Z.G. The Effect of C-Peptide on Cognitive Dysfunction and Hippocampal Apoptosis in Type 1 Diabetic Rats. Diabetes 2005;54:1497–505.Kamboj S.S., Sandhir R. Protective effect of N-acetylcysteine supplementation on mitochondrial oxidative stress and mitochonrial enzymes in cerebral cortex of streptozotocin-treated diabetic rats. Mitochondron 2011;11(1):214–22.Захаров В.В., Сосина В.Б. Применение антигипоксантов в лечении когнитивных нарушений у больных сахарным диабетом. Неврол журн 2008;5:39–43.Ziegler D., Movsesyan L., Mancovsky B. et al. Treatment of symptomatic polyneuropathy with Actovegin in type 2 diabetic patients. Diabetes Care 2009;32:1479–84.</div>

The authors declare that there are no conflicts of interest present.